BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23211970)

  • 21. Facile synthesis of 1,3-thiazolidin-4-ones as antitubercular agents.
    Subhedar DD; Shaikh MH; Arkile MA; Yeware A; Sarkar D; Shingate BB
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1704-8. PubMed ID: 26927426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and antitubercular activities in vitro and in vivo of novel Schiff bases of isoniazid.
    Hearn MJ; Cynamon MH; Chen MF; Coppins R; Davis J; Joo-On Kang H; Noble A; Tu-Sekine B; Terrot MS; Trombino D; Thai M; Webster ER; Wilson R
    Eur J Med Chem; 2009 Oct; 44(10):4169-78. PubMed ID: 19524330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
    Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M
    Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of new 1,3,5-triazine scaffolds with potent activity against Mycobacterium tuberculosis H37Rv.
    Sunduru N; Gupta L; Chaturvedi V; Dwivedi R; Sinha S; Chauhan PM
    Eur J Med Chem; 2010 Aug; 45(8):3335-45. PubMed ID: 20452706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and development of ((4-methoxyphenyl)carbamoyl) (5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl)amide analogues as Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors.
    Krishna VS; Zheng S; Rekha EM; Nallangi R; Sai Prasad DV; George SE; Guddat LW; Sriram D
    Eur J Med Chem; 2020 May; 193():112178. PubMed ID: 32171154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salicylanilide esters of N-protected amino acids as novel antimicrobial agents.
    Imramovský A; Vinsová J; Férriz JM; Buchta V; Jampílek J
    Bioorg Med Chem Lett; 2009 Jan; 19(2):348-51. PubMed ID: 19081718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, and evaluation of new 2-(quinoline-4-yloxy)acetamide-based antituberculosis agents.
    Borsoi AF; Paz JD; Abbadi BL; Macchi FS; Sperotto N; Pissinate K; Rambo RS; Ramos AS; Machado D; Viveiros M; Bizarro CV; Basso LA; Machado P
    Eur J Med Chem; 2020 Apr; 192():112179. PubMed ID: 32113048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.
    Desai NC; Somani H; Trivedi A; Bhatt K; Nawale L; Khedkar VM; Jha PC; Sarkar D
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1776-83. PubMed ID: 26920799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 8-Hydroxyquinolines are bactericidal against Mycobacterium tuberculosis.
    Odingo JO; Early JV; Smith J; Johnson J; Bailey MA; Files M; Guzman J; Ollinger J; Korkegian A; Kumar A; Ovechkina Y; Parish T
    Drug Dev Res; 2019 Aug; 80(5):566-572. PubMed ID: 30893501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies.
    Gemma S; Savini L; Altarelli M; Tripaldi P; Chiasserini L; Coccone SS; Kumar V; Camodeca C; Campiani G; Novellino E; Clarizio S; Delogu G; Butini S
    Bioorg Med Chem; 2009 Aug; 17(16):6063-72. PubMed ID: 19620006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-activity relationships of 2-aminothiazoles effective against Mycobacterium tuberculosis.
    Meissner A; Boshoff HI; Vasan M; Duckworth BP; Barry CE; Aldrich CC
    Bioorg Med Chem; 2013 Nov; 21(21):6385-97. PubMed ID: 24075144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of 2-Amino Benzothiazoles with Bactericidal Activity against Mycobacterium tuberculosis.
    Bonnett S; Jee JA; Chettiar S; Ovechkina Y; Korkegian A; Greve E; Odingo J; Parish T
    Microbiol Spectr; 2023 Feb; 11(1):e0497422. PubMed ID: 36688635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigating the spectrum of biological activity of ring-substituted salicylanilides and carbamoylphenylcarbamates.
    Otevrel J; Mandelova Z; Pesko M; Guo J; Kralova K; Sersen F; Vejsova M; Kalinowski DS; Kovacevic Z; Coffey A; Csollei J; Richardson DR; Jampilek J
    Molecules; 2010 Nov; 15(11):8122-42. PubMed ID: 21072023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New insights into the SAR and drug combination synergy of 2-(quinolin-4-yloxy)acetamides against Mycobacterium tuberculosis.
    Giacobbo BC; Pissinate K; Rodrigues-Junior V; Villela AD; Grams ES; Abbadi BL; Subtil FT; Sperotto N; Trindade RV; Back DF; Campos MM; Basso LA; Machado P; Santos DS
    Eur J Med Chem; 2017 Jan; 126():491-501. PubMed ID: 27914363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antitubercular activity of various nitro(triazole/imidazole)-based compounds.
    Papadopoulou MV; Bloomer WD; Rosenzweig HS
    Bioorg Med Chem; 2017 Nov; 25(21):6039-6048. PubMed ID: 28993106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nontoxic Metal-Cyclam Complexes, a New Class of Compounds with Potency against Drug-Resistant Mycobacterium tuberculosis.
    Yu M; Nagalingam G; Ellis S; Martinez E; Sintchenko V; Spain M; Rutledge PJ; Todd MH; Triccas JA
    J Med Chem; 2016 Jun; 59(12):5917-21. PubMed ID: 27214150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines.
    Tonelli M; Novelli F; Tasso B; Sparatore A; Boido V; Sparatore F; Cannas S; Molicotti P; Zanetti S; Parapini S; Loddo R
    Bioorg Med Chem; 2014 Dec; 22(24):6837-45. PubMed ID: 25464882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of novel [1,2]-diamines with antituberculosis activity.
    Meng Q; Luo H; Chen Y; Wang T; Yao Q
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5372-5. PubMed ID: 19682895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of novel acetohydroxyacid synthase inhibitors as active agents against Mycobacterium tuberculosis by virtual screening and bioassay.
    Wang D; Zhu X; Cui C; Dong M; Jiang H; Li Z; Liu Z; Zhu W; Wang JG
    J Chem Inf Model; 2013 Feb; 53(2):343-53. PubMed ID: 23316686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.